<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5072">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04382378</url>
  </required_header>
  <id_info>
    <org_study_id>FAP042017</org_study_id>
    <nct_id>NCT04382378</nct_id>
  </id_info>
  <brief_title>Effects of NMES in Critically Ill Patients</brief_title>
  <acronym>NUMBERNMES</acronym>
  <official_title>Effects of Different Regimen Protocols of NMES in COVID 19 Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Escola Superior de Ciencias da Saude</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Escola Superior de Ciencias da Saude</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Muscle wasting occurred early and rapidly in critically ill patients. Early therapeutic&#xD;
      strategies to either maintain muscle structure and function should be encouraged.&#xD;
      Neuromuscular electrical stimulation (NMES) is an attractive intervention to maintain muscle&#xD;
      mass and strength in critically ill patients during the first week of ICU stay. This study&#xD;
      will test the hypothesis that the number of contraction per day evoked by NMES in the first&#xD;
      two weeks of illness may influence in muscle wasting, with beneficial effects on the physical&#xD;
      and functional status in mechanically ventilated patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with prolonged mechanical ventilation require deep sedation and mechanical&#xD;
      ventilation, factors predisposing to the development of skeletal muscle wasting and acute&#xD;
      muscle atrophy. Strategies to attenuate this process must be used. The neuromuscular&#xD;
      electrostimulation (NMES) leads to the application of electrical currents in the skin aiming&#xD;
      at muscle contraction, has beneficial effects for the population of critical patients.&#xD;
      However, the number of contractions induced by NMES to attenuate the loss of muscle mass in&#xD;
      this population is not yet established. This randomized controlled trial with 120 patients&#xD;
      that will be randomized to one of the 3 study groups: 100 continuous daily contractions&#xD;
      (100Cd), 50 continuous daily contractions (50Cd) and control group. Muscle thickness,&#xD;
      NMES-induced strength, and clinical and functional parameters at the time of discharge from&#xD;
      the ICU and hospital discharge will be assessed daily. The results of this project will&#xD;
      provide an important contribution to the understanding of the mechanisms associated with NMES&#xD;
      treatment as a tool to minimize the effects of muscle disuse, as well as providing scientific&#xD;
      support for the clinical use of this resource in the treatment in the light of the policies'&#xD;
      health system.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The assessors will be blinded to randomization</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>cross sectional area of rectus femoris</measure>
    <time_frame>from baseline to 14 days of therapy</time_frame>
    <description>change of muscle wasting assessed by ultrassonogropahy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>echointensity of rectus femoris</measure>
    <time_frame>from baseline to 14 days of therapy</time_frame>
    <description>change of echointensity of rectus femoris assessed by ultrassonography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>muscle strength</measure>
    <time_frame>from baseline to 14 days of therapy</time_frame>
    <description>change of evoked peak torque of quadriceps femoris assesssed by unvolitional testing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional status</measure>
    <time_frame>from baseline to 14 days of therapy</time_frame>
    <description>Functional status assessed by IMS scale ranged from 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU acquired weakness</measure>
    <time_frame>from baseline to 14 days of therapy</time_frame>
    <description>percent of patients that have muscle strength assessed by Medical Research Council Sum-Score (MRC-SS) lower than 48</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Mechanical Ventilation Complication</condition>
  <condition>Muscle Weakness Condition</condition>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Group that will receive a standard care from physiotherapy staff not involved in delivering the intervention whenever feasible.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>50 electrically evoked contractions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group that will receive a standard care from physiotherapy staff plus neuromuscular electrical stimulation with the following parameters: pulsed current; freqeuncy 50Hz; pulse witdh 400 us, current intensity that get level 4/5 of evoked contractions proposed by Segers et al; on/off time and duration of therapy that allow 50 ellectrically evoked contractions with surface electrodes positioned on the quadriceps femoris.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>100 electrically evoked contractions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group that will receive a standard care from physiotherapy staff plus neuromuscular electrical stimulation with the following parameters: pulsed current; freqeuncy 50Hz; pulse witdh 400 us, current intensity that get level 4/5 of evoked contractions proposed by Segers et al; on/off time and duration of therapy that allow 100 ellectrically evoked contractions with surface electrodes positioned on the quadriceps femoris.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>neuromuscular electrical stimulation</intervention_name>
    <description>application of an electric current through electrodes placed on the skin over the targeted musclesto induce skeletal muscle contractions</description>
    <arm_group_label>100 electrically evoked contractions</arm_group_label>
    <arm_group_label>50 electrically evoked contractions</arm_group_label>
    <other_name>NMES</other_name>
    <other_name>transcutenaous electrical nerve stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18 years or older&#xD;
&#xD;
          -  Intubated and expected to remain invasively mechanically ventilated the day after&#xD;
             tomorrow&#xD;
&#xD;
          -  laboratory confirmed COVID-19 (diagnosis of SARS-CoV-2 via reverse transcriptase&#xD;
             polymerase chain reaction as per the World Health Organization protocol or by nucleic&#xD;
             acid based isothermal amplification)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Dependent for activities of daily living in the month prior to current ICU admission&#xD;
             (gait aids are acceptable).&#xD;
&#xD;
          -  Documented cognitive impairment.&#xD;
&#xD;
          -  Proven or suspected spinal cord injury or other neuromuscular disease that will result&#xD;
             in permanent or prolonged weakness (not including ICU acquired weakness)&#xD;
&#xD;
          -  Death is deemed inevitable as a result of the current illness and either the patient&#xD;
             or treating clinical or substitute decision maker are not committed to full active&#xD;
             treatment&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  patients with unstable fractures in the vertebral column and lower limbs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>VINICIUS ZACARIAS MALDANER D SILVA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Secretaria de Saúde do Distrito Federal</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>VINICIUS ZACARIAS MALDANER D SILVA</last_name>
    <phone>6135462517</phone>
    <email>viniciusmaldaner@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Secretaria de Saúde do Distrito Federal</name>
      <address>
        <city>Brasilia</city>
        <state>DF</state>
        <zip>700000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vinicius Silva, PhD</last_name>
      <phone>+55 61 20172145</phone>
      <email>viniciius.maldaner@escs.edu.br</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2020</study_first_posted>
  <last_update_submitted>March 11, 2021</last_update_submitted>
  <last_update_submitted_qc>March 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Escola Superior de Ciencias da Saude</investigator_affiliation>
    <investigator_full_name>Vinicius Zacarias Maldaner da silva</investigator_full_name>
    <investigator_title>Principal Inverstigator</investigator_title>
  </responsible_party>
  <keyword>muscular atrophy</keyword>
  <keyword>electric stimulation therapy</keyword>
  <keyword>intensive care units</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

